NCT00083551 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Thalidomide 400 QD during induction, 100 mg QD between transplants, 200 mg QD post transplant, 100 mg QD during year one of maintenance, and 50 mg QD during second year of maintenance.
- id
- FG000
- title
- Thalidomide
- description
- Patient received no thalidomide during induction, consolidation, and maintenance therapy.
- id
- FG001
- title
- No Thalidomide
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 323
- group Id
- FG001
- num Subjects
- 345
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 323
- group Id
- FG001
- num Subjects
- 345
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Overall Study
Complete source fields
- groups
- description
- Thalidomide 400 QD during induction, 100 mg QD between transplants, 200 mg QD post transplant, 100 mg QD during year one of maintenance, and 50 mg QD during second year of maintenance.
- id
- FG000
- title
- Thalidomide
- description
- Patient received no thalidomide during induction, consolidation, and maintenance therapy.
- id
- FG001
- title
- No Thalidomide
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 323
- group Id
- FG001
- num Subjects
- 345
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 323
- group Id
- FG001
- num Subjects
- 345
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Overall Study
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle